Sectors
BBOT
BridgeBio Oncology Therapeutics, Inc.
8.80
1 x 6.49
2 x 11.30
bid
ask
+
0.06
0.69%
2 @ 05:01 PM
8.63 -0.17 (1.93%)
| Ytd | -29.71% | |
| 1y | -1.57% |
8.41
day range
9.20
7.00
52 week range
14.87
| Open | 8.72 | Prev Close | 8.74 | Low | 8.41 | High | 9.20 | Mkt Cap | 705.53M |
| Vol | 476.04K | Avg Vol | 370.38K | EPS | -2.27 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.36 | Short Ratio | 4.43 | Inst. Own | 52.88% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 8.60 | 200-d Avg | 9.88 | 1yr Est | 24.20 |
| Income Statement | |||
| Operating Expenses | 60.19M | ||
| Research and Development Expense | 49.23M | ||
| Selling, General and Administrative Expense | 10.96M | ||
| Operating Income | -60.19M | ||
| Net Income | -56.45M | ||
| Net Income Common Stock | -56.45M | ||
| Net Income Common Stock (USD) | -56.45M | ||
| Consolidated Income | -56.45M | ||
| Earnings per Basic Share | -705.20 | ||
| Earnings per Basic Share (USD) | -705.20 | ||
| Earnings per Diluted Share | -705.20 | ||
| Earning Before Interest & Taxes (EBIT) | -56.45M | ||
| Earning Before Interest & Taxes (USD) | -56.45M | ||
| Weighted Average Shares | 80.05M | ||
| Weighted Average Shares Diluted | 80.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 54.20M | ||
| Cash and Equivalents (USD) | 54.20M | ||
| Investments | 290.07M | ||
| Investments Current | 171.65M | ||
| Investments Non-Current | 118.42M | ||
| Trade and Non-Trade Receivables | 661.00K | ||
| Current Assets | 242.38M | ||
| Property, Plant & Equipment Net | 2.98M | ||
| Total Assets | 376.71M | ||
| Debt Current | 554.00K | ||
| Total Debt | 2.51M | ||
| Current Liabilities | 51.63M | ||
| Debt Non-Current | 1.96M | ||
| Total Liabilities | 53.59M | ||
| Accumulated Retained Earnings (Deficit) | -455.13M | ||
| Accumulated Other Comprehensive Income | -959.00K | ||
| Shareholders Equity | 323.11M | ||
| Shareholders Equity (USD) | 323.11M | ||
| Assets Non-Current | 134.33M | ||
| Total Debt (USD) | 2.51M | ||
| Liabilities Non-Current | 1.96M | ||
| Trade and Non-Trade Payables | 7.71M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 191.00K | ||
| Net Cash Flow from Financing | 37.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.41M | ||
| Capital Expenditure | -47.00K | ||
| Issuance (Purchase) of Equity Shares | 37.00K | ||
| Net Cash Flow from Investing | 45.73M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 45.78M | ||
| Net Cash Flow from Operations | -44.36M | ||
| Share Based Compensation | 7.23M | ||